Pre-order Enquiry
Request Free Sample
Global Cancer Immunotherapy Market Research Report 2022 - Market Size, Current Insights and Development Trends
SKU ID : Maia-20948470 | Publishing Date : 18-May-2022 | No. of pages : 108
Cancer immunotherapy or, immuno-oncology, is the treatment that utilises the body’s own immune system to combat cancer. These immunotherapy treatments either boost the body’s immune system or may act on immune system to identify and destroy the cancerous cells. Immunotherapy is a type of personalized medicine that works better for certain types of cancer.
The Cancer Immunotherapy market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Cancer Immunotherapy market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Cancer Immunotherapy market.
Major Players in the Cancer Immunotherapy market are:
Novartis AG
Merck & Co., Inc.,
Chugai
Otsuka Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co
Takara Bio
Roche Japan
Bayer Ag
Immunomedics Inc
Fujifilm
Eli Lilly and Company
Daiichi Sankyo Company Limited
Oncolys BioPharma
Celgene
Astellas Pharma Inc.
On the basis of types, the Cancer Immunotherapy market is primarily split into:
Monoclonal Antibodies
Cytokines & Immunomodulators
Cancer Vaccines
Checkpoint Inhibitors
On the basis of applications, the market covers:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Head and Neck Cancer
Others
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
2021
The Cancer Immunotherapy market has witnessed a growth from USD XX million to USD XX million from 2017 to 2022. With a CAGR of X.X%, this market is estimated to reach USD XX million in 2029.
The report focuses on the Cancer Immunotherapy market size, segment size (mainly covering product type, application, and geography), competitor landscape, recent status, and development trends. Furthermore, the report provides strategies for companies to overcome threats posed by COVID-19.
Technological innovation and advancement will further optimize the performance of the product, enabling it to acquire a wider range of applications in the downstream market. Moreover, customer preference analysis, market dynamics (drivers, restraints, opportunities), new product release, impact of COVID-19, regional conflicts and carbon neutrality provide crucial information for us to take a deep dive into the Cancer Immunotherapy market.
Major Players in the Cancer Immunotherapy market are:
Novartis AG
Merck & Co., Inc.,
Chugai
Otsuka Pharmaceutical Co., Ltd.
Ono Pharmaceutical Co
Takara Bio
Roche Japan
Bayer Ag
Immunomedics Inc
Fujifilm
Eli Lilly and Company
Daiichi Sankyo Company Limited
Oncolys BioPharma
Celgene
Astellas Pharma Inc.
On the basis of types, the Cancer Immunotherapy market is primarily split into:
Monoclonal Antibodies
Cytokines & Immunomodulators
Cancer Vaccines
Checkpoint Inhibitors
On the basis of applications, the market covers:
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Melanoma
Head and Neck Cancer
Others
Major Region
s or countries covered in this report:United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Others
Years considered for this report:
Historical Years:
2017-2021Base Year:
2021Estimated Year:
2022Forecast Period:
2022-2029Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Request Sample
Request Discount
